Logo image of FENC

FENNEC PHARMACEUTICALS INC (FENC) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:FENC - CA31447P1009 - Common Stock

7.62 USD
-0.15 (-1.93%)
Last: 1/12/2026, 8:00:00 PM
7.62 USD
0 (0%)
After Hours: 1/12/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
FENC revenue by date.FENC revenue by date.
1.54M21.252M
1,280.00%
47.538M
123.69%
45.745M
-3.77%
78.209M
70.97%
93.471M
19.51%
137.13M
46.71%
171.5M
25.06%
176.18M
2.73%
181.38M
2.95%
183.44M
1.14%
65.043M
-64.54%
EBITDA
YoY % growth
FENC ebitda by date.FENC ebitda by date.
N/AN/AN/A
216.67%
5.712M
-20.00%
41.718M
630.36%
49.878M
19.56%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
FENC ebit by date.FENC ebit by date.
-22.59M
-31.18%
-12.771M
43.47%
2.568M
120.11%
-1.967M
-176.61%
22.725M
1,255.09%
33.846M
48.94%
61.455M
81.57%
99.623M
62.11%
98.202M
-1.43%
114.47M
16.57%
125.47M
9.61%
41.542M
-66.89%
Operating Margin
FENC operating margin by date.FENC operating margin by date.
-1,466.88%-60.09%5.40%-4.30%29.06%36.21%44.82%58.09%55.74%63.11%68.40%63.87%
EPS
YoY % growth
FENC eps by date.FENC eps by date.
-0.90
-34.33%
-0.61
32.22%
0.00
100.00%
-0.13
-227,846,112,347,928,060.00%
0.67
625.81%
1.05
58.36%
3.14
198.31%
4.48
42.53%
5.14
14.81%
5.46
6.15%
5.81
6.54%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.04
174.80%
0.12
412.38%
0.19
273.86%
0.14
801.25%
0.21
360.23%
0.15
22.45%
0.20
6.67%
0.24
74.55%
0.56
171.60%
Revenue
Q2Q % growth
14.027M
77.00%
17.832M
103.77%
19.772M
104.85%
18.729M
50.29%
21.612M
54.07%
18.951M
6.28%
19.981M
1.06%
21.379M
14.15%
27.407M
26.81%
EBITDA
Q2Q % growth
4.488M
780.00%
13.566M
1,123.08%
5.814M
533.33%
7.854M
220.83%
14.586M
225.00%
7.752M
-42.86%
9.384M
61.40%
10.812M
37.66%
21.93M
50.35%
EBIT
Q2Q % growth
1.656M
277.30%
7.306M
1,004.21%
3.499M
228.07%
4.658M
2,564.55%
8.093M
388.71%
5.61M
-23.21%
7.242M
106.97%
8.772M
88.32%
19.89M
145.77%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.02
90.48%
-0.020.008.37%
Q2 2025
Q2Q % growth
-0.11
45.00%
-0.04-0.07-199.56%
Q1 2025
Q2Q % growth
-0.04
-108.51%
-0.090.0555.84%
Q4 2024
Q2Q % growth
-0.06
40.00%
0.17-0.23-135.44%
Q3 2024
Q2Q % growth
-0.21
-200.00%
-0.09-0.12-128.76%
Q2 2024
Q2Q % growth
-0.20
4.76%
-0.03-0.17-539.32%
Q1 2024
Q2Q % growth
0.47
304.35%
0.270.2075.87%
Q4 2023
Q2Q % growth
-0.10
61.54%
-0.02-0.08-400.20%
Q3 2023
Q2Q % growth
-0.07
77.42%
-0.120.0542.81%
Q2 2023
Q2Q % growth
-0.21
-10.53%
-0.16-0.05-31.55%
Q1 2023
Q2Q % growth
-0.23
-64.29%
-0.21-0.02-7.48%
Q4 2022
Q2Q % growth
-0.26
-44.44%
-0.270.013.75%
Q3 2022
Q2Q % growth
-0.31
-93.75%
-0.19-0.12-67.29%
Q2 2022
Q2Q % growth
-0.19
-26.67%
-0.14-0.05-36.30%
Q1 2022
Q2Q % growth
-0.14
22.22%
-0.140.001.96%
Q4 2021
Q2Q % growth
-0.18
-38.46%
0.76-0.94-123.61%
Q3 2021
Q2Q % growth
-0.16
33.33%
-0.170.017.73%
Q2 2021
Q2Q % growth
-0.15
28.57%
-0.190.0421.78%
Q1 2021
Q2Q % growth
-0.18
5.26%
-0.13-0.05-35.75%
Q4 2020
Q2Q % growth
-0.13 -0.190.0632.92%
Q3 2020
Q2Q % growth
-0.24 -0.19-0.05-23.84%
Q2 2020
Q2Q % growth
-0.21 -0.18-0.03-16.53%
Q1 2020
Q2Q % growth
-0.19 -0.190.000.21%
FENC Yearly EPS VS EstimatesFENC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
12.462M
78.69%
11.482M980K8.54%
Q2 2025
Q2Q % growth
9.652M
32.91%
9.707M-55K-0.57%
Q1 2025
Q2Q % growth
8.751M
-65.52%
8.345M406K4.87%
Q4 2024
Q2Q % growth
7.925M
-18.59%
17.051M-9.126M-53.52%
Q3 2024
Q2Q % growth
6.974M
12.77%
9.162M-2.188M-23.88%
Q2 2024
Q2Q % growth
7.262M
118.41%
11.269M-4.007M-35.56%
Q1 2024
Q2Q % growth
25.377M
1,413.24%
19.254M6.123M31.80%
Q4 2023
Q2Q % growth
9.735M
532.14%
8.843M892K10.09%
Q3 2023
Q2Q % growth
6.184M 5.443M741K13.61%
Q2 2023
Q2Q % growth
3.325M 3.81M-485K-12.73%
Q1 2023
Q2Q % growth
1.677M 1.884M-207K-10.99%
Q4 2022
Q2Q % growth
1.54M 759.727K780.273K102.70%
Q4 2021
Q2Q % growth

-100.00%
34M-34M-100.00%
Q3 2020
Q2Q % growth
484.5K-484.5K-100.00%
FENC Yearly Revenue VS EstimatesFENC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS37.5% -63.58% 17.33% -406.93%
Revenue2.08% -7.18% 2.47% -3.94%